Mechanisms of human drug-induced anaphylaxis.

J Allergy Clin Immunol

Department "Auto-immunité et Hypersensibilités," DMU BioGeM, APHP, Hôpital Bichat, Paris, France; "Inflammation, Microbiome and Immunosurveillance" INSERM UMR 996, Faculté de Pharmacie, Université Paris-Saclay, Châtenay-Malabry, France. Electronic address:

Published: April 2021

Drug-induced anaphylaxis is a hyperacute reaction affecting multiple organs that can be of fatal consequence. Its incidence is increasing, consistent with a global increased sensitization to various allergens and drugs in the population. Few risk factors and mechanisms have been identified from human studies due to the rarity of anaphylactic events and their unpredictability. This systemic reaction is caused by the rapid release of a large range of functionally diverse mediators, including histamine and platelet-activating factor as the main drivers identified. Mechanisms defined from models of experimental anaphylaxis identify drug-specific antibodies of the IgE and IgG class that link the drug to antibody receptors on multiple cell types, causing their activation and mediator release. In the case of drugs with peculiar chemical structures, antibodies may not be necessary because drug-binding receptors, such as Mas-related G protein-coupled receptor member X2, have been identified. This review describes the complex reaction leading to drug-induced anaphylaxis that can involve various antibody classes, various cell types-including mast cells, neutrophils, platelets, basophils, macrophages, and monocytes-and their mediators and receptors that, importantly, can be activated alone or in association to participate in the severity of the reaction.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2021.02.013DOI Listing

Publication Analysis

Top Keywords

drug-induced anaphylaxis
12
mechanisms human
4
human drug-induced
4
anaphylaxis
4
anaphylaxis drug-induced
4
anaphylaxis hyperacute
4
reaction
4
hyperacute reaction
4
reaction multiple
4
multiple organs
4

Similar Publications

Drug allergy.

Allergy Asthma Clin Immunol

January 2025

Division of Allergy & Immunology, Department of Medicine, Queen's University, Kingston, ON, Canada.

Drug allergy encompasses a spectrum of immunologically-mediated hypersensitivity reactions (HSRs) with varying mechanisms and clinical presentations. This type of adverse drug reaction (ADR) not only affects patient quality of life, but may also lead to delayed treatment, unnecessary investigations, and increased morbidity and mortality. Given the spectrum of symptoms associated with the condition, diagnosis can be challenging.

View Article and Find Full Text PDF

The development of murine bone marrow-derived mast cells expressing functional human MRGPRX2 for and studies.

Front Immunol

January 2025

Department of Basic and Translational Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Introduction: A subtype of human mast cells (MCs) found in the skin and to a lesser extent in the lung and gut express a novel G protein-coupled receptor (GPCR) known as Mas-related GPCR-X2 (MRGPRX2, mouse counterpart MrgprB2). In addition to drug-induced pseudoallergy and cutaneous disorders, MrgprB2 contributes to ulcerative colitis, IgE-mediated lung inflammation and systemic anaphylaxis. Interestingly, most agonists activate MRGPRX2 with higher potency than MrgprB2.

View Article and Find Full Text PDF

Introduction: Anaphylaxis is an acute life-threatening allergy, most commonly provoked by food, venom, or drugs. There is limited data regarding differences in symptomatology between anaphylaxis provoked by different triggers. This study aimed to assess sociodemographic characteristics, clinical symptoms, and management of anaphylaxis, according to triggers in adults.

View Article and Find Full Text PDF

Allergic clinical symptoms and distribution of stimulation index of drug lymphocyte stimulation test for local anesthetics.

Oral Maxillofac Surg

November 2024

Department of Dental Anesthesiology and Orofacial Pain Management, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.

Objective: The Drug Lymphocyte Stimulation Test (DLST), recognized for its safety as an allergy diagnostic modality, has been acknowledged for its utility in diagnosing drug-induced pathological conditions. However, reports elucidating DLST outcomes concerning local anesthetics are notably scarce.

Materials And Methods: An exhaustive analysis was conducted on the DLST results pertaining to local anesthetics derived from 571 patients presenting with suspected allergies to these specific agents.

View Article and Find Full Text PDF
Article Synopsis
  • Immunoglobulin E (IgE)-mediated allergic reactions to penicillin antibiotics can be severe and potentially deadly, making their diagnosis after anaphylactic deaths challenging due to non-specific indicators.
  • This study utilized a liquid chromatography-mass spectrometry (LC-MS) untargeted metabolomics approach to identify forensic biomarkers related to fatal anaphylactic shock caused by four types of penicillin antibiotics.
  • The research identified 24 distinct metabolites linked to allergic reactions, highlighting six common ones that formed a strong biomarker model for diagnosing penicillin-induced anaphylaxis, suggesting that metabolomic profiling can enhance post-mortem investigations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!